| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $50,138,412 ) (Continued on the next page) |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS115441 | Novel mechanisms regulating protein interaction and pain | 000 | 3 | NIH | 1/4/2022 | $462,722 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244749 | Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators | 001 | 3 | NIH | 6/10/2022 | $50,374 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244749 | Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators | 000 | 3 | NIH | 3/1/2022 | $566,699 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37CA234428 | Monitoring neoadjuvant chemotherapy of breast cancer using 3D subharmonic aided pressure estimation | 000 | 4 | NIH | 4/27/2022 | $431,752 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM132611 | Regulation of inositol trisphosphate receptors | 001 | 3 | NIH | 6/9/2022 | $32,180 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM132611 | Regulation of inositol trisphosphate receptors | 000 | 3 | NIH | 12/20/2021 | $289,626 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG058884 | Neurodegeneration and Microvascular Damage in Alzheimer's Disease | 001 | 4 | NIH | 6/6/2022 | -$79,083 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG058884 | Neurodegeneration and Microvascular Damage in Alzheimer's Disease | 000 | 4 | NIH | 4/25/2022 | $469,083 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR076941 | Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium | 001 | 3 | NIH | 6/17/2022 | $61,465 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR076941 | Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium | 000 | 3 | NIH | 1/31/2022 | $614,648 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM134931 | tRNA in codon usage | 001 | 3 | NIH | 6/9/2022 | $213,326 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM134931 | tRNA in codon usage | 000 | 3 | NIH | 2/17/2022 | $491,399 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236853 | BCLW in lymphoma survival and resistance to targeted BCL2 family therapies | 000 | 3 | NIH | 11/30/2021 | $386,821 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03AI169437 | An animal model for cytomegalovirus-induced pathology in the developing retina | 000 | 1 | NIH | 2/1/2022 | $78,000 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA258849 | Provider Support and Patient Outreach in Lung Cancer Screening | 000 | 1 | NIH | 4/1/2022 | $713,095 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DA022727 | Cell-Contact Mediated Mechanisms Assembling Synapses | 000 | 14 | NIH | 11/26/2021 | $381,669 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DA022727 | Cell-Contact Mediated Mechanisms Assembling Synapses | 002 | 14 | NIH | 3/25/2022 | $0 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DA022727 | Cell-Contact Mediated Mechanisms Assembling Synapses | 001 | 14 | NIH | 3/24/2022 | $42,408 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA263506 | MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | 000 | 1 | NIH | 3/16/2022 | $644,810 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM130889 | Structure and Function of DNA Polymerase Theta | 000 | 5 | NIH | 2/8/2022 | $349,107 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI168975 | Role of rRNA-derived short non-coding RNAs in innate immune response | 000 | 1 | NIH | 2/7/2022 | $234,000 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 1 | NIH | 12/24/2021 | $540,022 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA259750 | Contrast-Enhanced Ultrasound for Diagnosis and Therapy of Cholangiocarcinoma | 000 | 1 | NIH | 11/29/2021 | $218,790 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03AG070535 | SIRT6 as a novel therapeutic target in aging and age-related osteoarthritis | 000 | 2 | NIH | 6/1/2022 | $78,000 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG073349 | Targeting cell senescence in a novel model of spontaneous disc degeneration | 000 | 2 | NIH | 6/3/2022 | $571,525 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI154772 | Immunoregulatory effect of microparticle delivered STING agonist in the control of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS) | 000 | 2 | NIH | 3/10/2022 | $195,966 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03AI156373 | Control of lipid droplet homeostasis by Chlamydia | 000 | 2 | NIH | 6/6/2022 | $78,000 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI159798 | A System to Study Salmonella Typhi Infection?and Immunity | 000 | 2 | NIH | 2/18/2022 | $195,000 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM138943 | Regulation of Mutationally Activated Gq/11 | 000 | 2 | NIH | 1/17/2022 | $280,800 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI160189 | IL-37: a novel regulator of inflammation in CNS autoimmunity | 000 | 2 | NIH | 2/10/2022 | $390,000 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AR077332 | Pharmacologic Intervention for Ectopic Calcification | 000 | 2 | NIH | 3/4/2022 | $157,769 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AR077332 | Pharmacologic Intervention for Ectopic Calcification | 001 | 2 | NIH | 6/9/2022 | $15,778 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK125897 | ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease | 002 | 2 | NIH | 6/7/2022 | $145,860 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK125897 | ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease | 001 | 2 | NIH | 3/29/2022 | $47,718 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK125897 | ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease | 000 | 2 | NIH | 1/25/2022 | $429,469 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM140733 | Mechanism of Viral Genome Delivery into Cells | 000 | 1 | NIH | 1/12/2022 | $28,355 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA256945 | Mechanisms of cell death in cutaneous melanoma | 000 | 2 | NIH | 4/20/2022 | $463,189 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI156490 | Discovering new genes involved in monocyte-mediated protective anti-viral innate immunity through the generation of mice with targeted mutations | 000 | 2 | NIH | 5/16/2022 | $195,000 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR078440 | Caspase-1 Activation by the Inflammasomes | 000 | 2 | NIH | 4/29/2022 | $526,598 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03CA252779 | Lung epithelial lineage-specific factors in the control of immune system evasion genes in tumor cells | 000 | 2 | NIH | 1/18/2022 | $78,000 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30DK127639 | Silencing the uroguanylin-GUCY2C gut-brain axis mediates leptin resistance in obesity | 002 | 2 | NIH | 5/20/2022 | -$1 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30DK127639 | Silencing the uroguanylin-GUCY2C gut-brain axis mediates leptin resistance in obesity | 000 | 2 | NIH | 12/6/2021 | $47,286 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30DK127639 | Silencing the uroguanylin-GUCY2C gut-brain axis mediates leptin resistance in obesity | 001 | 2 | NIH | 4/28/2022 | $717 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | UG3CA247605 | Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy | 000 | 2 | NIH | 5/23/2022 | $316,568 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK125541 | Bio-Psycho-Social Drivers of Disparities in Liver Disease Progression among Korean Americans with Hepatitis B Infection | 000 | 2 | NIH | 3/28/2022 | $642,723 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F31NS120718 | Regulation of Development by LRP4 at Drosophila Peripheral Synapses | 000 | 2 | NIH | 2/3/2022 | $45,520 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI164490 | TrmD-targeting actinobacterial natural products as next generation antibiotics | 001 | 2 | NIH | 5/20/2022 | $831,545 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | K0133449 | Geriatric Academic Career Awards | 00 | 4 | HRSA | 5/23/2022 | $81,746 |
| | 2022 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T2537616 | Addiction Medicine Fellowship | 00 | 3 | HRSA | 5/10/2022 | $409,081 |
|
